ASCENDING SINGLE DOSE STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACO-DYNAMICS OF SRA-444 ADMINISTERED ORALLY TO HEALTHY ADULT SUBJECTS

Completed

• Conditions: Dementia; neurological disorder; 10011305

• Registration Number: NL-OMON30387
• Lead Sponsor: Wyeth

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 64

Inclusion Criteria

zie beneden

Exclusion Criteria

zie beneden

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>To assess the safety and tolerability of ascending single oral doses of<br /><br>SRA-444 in healthy adult subjects.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>To obtain preliminary PK and PD profiles of SRA-444 in healthy adult subjects.<br /><br>To evaluate the effect of a high-fat meal on the PK of SRA-444 administered to<br /><br>healthy adult subjects.</p><br>